BEZ.L (BEZ.L)

$7.5B
Market Cap
11.6
P/E Ratio
0.29
Beta
1.97%
Dividend Yield
Piotroski 5/9Altman Z 1.1 DistressROIC−WACC -1.9%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 1.1.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency for BEZ.L presents a notable divergence from typical value investing criteria, as the return on invested capital of 5.8% falls below the weighted average cost of capital at 7.7%, resulting in a negative spread that suggests potential value destruction or heavy reinvestment drag. Despite this capital inefficiency, profitability metrics are exceptionally concentrated; an 86.3% net margin indicates dominant pricing power or cost advantages, though revenue growth remains modest at 4.4%. Financial stability indicators show mixed signals: the Piotroski F-Score of 5/9 suggests moderate financial health with room for improvement in operational leverage or asset quality, while an Altman Z-Score of 1.1 flags a heightened probability of distress relative to historical bankruptcy thresholds.

Valuation metrics currently reflect a market discount that may be compensating for the negative ROIC-WACC spread and elevated insolvency risk rather than growth prospects. Trading at 11.6x earnings, the stock appears significantly cheaper than its implied fair value of $114 per share derived from discounted cash flow models, which assumes specific long-term growth trajectories not explicitly detailed in current performance data. This wide gap between market price and DCF-derived valuation implies that investors are heavily weighting the negative capital returns and low Z-Score over the company's exceptional margin profile, potentially pricing in a scenario where future free cash flows fail to materialize as modeled or where leverage constraints tighten further.

The risk-reward dynamic is defined by this tension between extreme undervaluation relative to intrinsic models and fundamental fragility indicators. While the negative spread indicates that current capital deployment does not generate returns exceeding the hurdle rate, the substantial cushion provided by valuation multiples against a DCF target suggests significant downside protection if operational performance improves or margin compression eases. Conversely, the proximity of the Altman Z-Score to distress territory combined with sub-par ROIC creates a binary outcome where any failure in capital allocation could exacerbate solvency concerns despite the high margins currently reported.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%7.7%9.7%
2%$140$96$70
3%$182$114$78
4%$266$140$90

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=7.7%, terminal growth 3%. Fair value $114 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
1.1
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

86.3%
Net Margin
5.8%
ROIC
7.7%
WACC
ROIC − WACC Spread: -1.9%— Negative spread.
+4.4%
Revenue Growth (YoY)
-19.2%
Earnings Growth (YoY)
1.2B
Free Cash Flow
17%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

2.32x
Debt / Equity
29.0x
Interest Coverage
-0.7x
Net Debt / EBITDA
18.80%
FCF Yield
1.2B
EBITDA

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

12.1
Forward P/E
PEG Ratio
203.03
Price/Book
8M
Avg Volume
$1295.00
52W High
$750.00
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in BEZ.L to visualize passive redemption contagion across ETFs and collateral stocks.

BEZ.L Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
BEZ.LEpicenterSCZETF5801.TLow Risk4004.TMed Risk5706.TLow RiskPLS.AXUnknownDPLM.LLow Risk
BEZ.L Price Drop (%)0

If BEZ.L (BEZ.L) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Furukawa Electric Co Ltd (5801.T) as the most exposed collateral stock, sharing 1 ETFs with BEZ.L. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

BEZ.L Ownership Dynamics

Ticker
BEZ.L

ETFs with Highest BEZ.L Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

BEZ.L Capital Efficiency

How efficiently does BEZ.L convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$1.2B
EBITDA
$1.2B
FCF Conversion
101%
Reinvestment Rate
-1%
101% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
5.8%
ROIC − WACC Spread
-1.9%

BEZ.L converts 101% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-1.9%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare BEZ.L to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.